Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-14

Clinical Trial Update: Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating a water-soluble ubiquinol supplement for effects on blood glucose, lipids, oxidative stress, and inflammation in diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ubiquinol (ubiquinol)

Snippet

Sponsor: Yeh | Conditions: Diabetes | Phase 2, Phase 3 | Status: COMPLETED